XXVI EFMC International Symposium on Medicinal Chemistry

 Virtual Event    August 29-September 2, 2021

List of Sessions

This year the sessions are grouped in 3 different themes:
1. Chemical Biology
2. Drug Discovery Projects
3. Technologies

In addition, the programme contains four open sessions : First Time Disclosures (I & II), Emerging Topics and Late Breaking News. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

Chemical Biology

  • Carbohydrate Recognition and Drug Design
    Session Chair: Dr Alexander Titz, Helmholtz Institute for Pharmaceutical Sciences, Germany

  • Chemical Approaches to Stem Cell Differentiation (ICBS Session)
    Session Chair: Prof. Colin Pouton, Monash University, Australia

  • Chemical Probes for Target Discovery and Validation
    Session Chair: Prof. Gyorgy Keseru, Hungarian Academy of Sciences, Hungary

  • Molecular Imaging Tools for Chemical Biology
    Session Chair: Dr Valle Palomo, CIB, Spain

  • Photochemistry in Drug Discovery: Photopharmacology, Phototoxicity and Synthesis (ACSMEDI Session)
    Session Chairs: Mr Timothy Henderson, MSD, United States & Dr Amjad Ali, MSD, United States

  • Small Molecules Targeting RNA Function and Processing
    Session Chair: Dr Maria Duca, University of Côte d'Azur, France

  • Target Deconvolution Strategies in Drug Discovery
    Session Chair: Prof. Paul Brennan, University of Oxford, United Kingdom

Drug Discovery Projects

  • Addressing Neglected and Emerging Viral Diseases with Small Molecules (AFMC Session)
    Session Chair: Prof. Esin Aki-Yalçin, Ankara University, Turkey

  • Breathing Life into Inhaled Drug Discovery: Challenges and Breakthroughs to the Clinic (ACSMEDI Session)
    Session Chair: Dr Nicole Goodwin, GSK, United States

  • Chemical Tools and Drug Discovery for Neuroinflammation (EuChemS Session)
    Session Chair: Dr Sonsoles Martin-Santamaria, Biological Research Center, Spain

  • New Strategies and Agents for Targeting Gram-Negative Pathogens
    Session Chair: Dr Vicky Steadman, Selcia, United Kingdom

  • Next Generation Drugs for Heart Failure
    Session Chair: Dr Alleyn Plowright, Wren Therapeutics, United Kingdom

  • Recent Advances in Anticancer Drug Discovery
    Session Chair: Prof. Roberto di Santo, Sapienza University of Rome, Italy

  • Targeting Fibrotic Diseases with Small Molecules
    Session Chair: Dr Christian Kuttruff, Boehringer Ingelheim, Germany

  • Tissue and Cell Specific Drug Delivery (EUFEPS Session)
    Session Chair: Prof. Sébastien Papot, University of Poitiers, France


  • Application of Artificial Intelligence in Drug Discovery Projects
    Session Chair: Dr Christopher Swain, Cambridge MedChem Consulting, United Kingdom

  • Biocatalysis & Late Stage Functionalisation
    Session Chair: Dr Radka Snajdrova, Novartis, Switzerland

  • Cryo-EM as an Emerging Tool for Small-Molecule Drug Discovery
    Session Chair: Dr Jean-Paul Renaud, Urania Therapeutics, France

  • Expanding Chemical Space through AI - Linking Synthesis Prediction and Automation
    Session Chair: Dr Ola Engkvist, AstraZeneca, Sweden

  • Innovative Synthesis for Medicinal Chemistry
    Session Chair: Prof. Cristina Nevado, University of Zurich, Switzerland

  • Novel Strategies and Methods for Drug Discovery and Development (CPA Session)
    Session Chair: Prof. Ke Ding, Jinan University, China

  • Prodrug Strategies in Drug Design and Discovery
    Session Chairs: Prof. Bernd Clement, University of Kiel, Germany & Prof. Jarkko Rautio, University of Eastern Finland, Finland

Open Sessions (selected from submitted abstracts)

  • First Time Disclosures (I & II)
    Session Chairs to be announced

  • Emerging Topics
    Session Chair to be announced

  • Late Breaking News
    Session Chair to be announced